UK rejects 30% of all minor variation applications
This article was originally published in SRA
Executive Summary
The UK Medicines and Healthcare products Regulatory Agency has rejected as many as around 30% of applications to make relatively minor changes to marketed drugs since the new Variations Regulation came into force in the European Union on 1 January 20101-3.